Chlamydia Screening and Positivity in Juvenile Detention Centers, United States, 2009–2011
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Chlamydia Screening and Positivity in Juvenile Detention Centers, United States, 2009–2011
  • Published Date:

    2014

  • Source:
    Women Health. 54(8):712-725
  • Language:
    English
Filetype[PDF-166.75 KB]


Details:
  • Alternative Title:
    Women Health
  • Personal Author:
  • Description:
    An estimated 2.9 million new chlamydia infections occur in the United States each year. Among women, chlamydia can lead to serious adverse outcomes, including pelvic inflammatory disease and infertility. Chlamydia prevalence is highest among females aged 15-19 years. Despite long-standing recommendations directed at young, sexually active females, screening remains sub-optimal. Juvenile detention centers (JDCs) are uniquely situated to screen and treat high-risk adolescents. From 2009-2011, performance measure data on chlamydia screening coverage (proportion of eligible females screened) and positivity (proportion of females tested who were positive) were available from 126 geographically-dispersed JDCs in the United States. These facilities reported screening 55.2% of females entering the facilities (149,923), with a facility-specific median of 66.4% (range: 0-100%). Almost half (44.4%) of facilities had screening coverage levels of 75-100%. This screening resulted in the detection of 12,305 chlamydial infections, for an overall positivity of 14.7% (facility-specific median = 14.9%, range: 0-36.9%). In linear regression analysis, chlamydia positivity was inversely associated with screening coverage: as coverage increased, positivity decreased. The burden of chlamydia in JDCs is substantial; facilities should continue to deliver recommended chlamydia screening and treatment to females and identify mechanisms to increase coverage.
  • Subject:
  • Pubmed ID:
    25189136
  • Pubmed Central ID:
    PMC6891050
  • Document Type:
    Journal Article
  • Funding:
    CC999999/ImCDC/Intramural CDC HHS/United States
  • Place as Subject:
    United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 317.00 KB]
    Personal Author:
    Bamberger, Ellen S.; Siegler, Efraim; Makler-Shiran, Einat; Patel, Mihir V.; Steinberg, Jordan M.; Gershtein, Rosa; Srugo, Isaac;
    Published Date:
    Oct 2003
    Source:
    Emerg Infect Dis. 9(10):1344-1346.
    File Type:
    Filetype[PDF - 317.00 KB]
  2. Filetype[PDF - 94.85 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    November 17, 2018
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2018 week 46
    Description:
    2018-46-table2C-H.pdf
    File Type:
    Filetype[PDF - 94.85 KB]
  3. Filetype[TIFF - 27.57 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
    Published Date:
    2015
    Description:
    Animated gif; to view animation, click Download.CDC recommends annyal chlamydia screenting for women 25 and under, as well as for older women at high risk.chlamydia-animated.gif
    File Type:
    Filetype[TIFF - 27.57 KB]
  4. Filetype[PDF - 94.58 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    September 21, 2018
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2018 week 37
    Description:
    2018-37-table2C-H.pdf
    File Type:
    Filetype[PDF - 94.58 KB]
  5. Filetype[PDF - 121.65 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National Notifiable Diseases Surveillance System.
    Published Date:
    12/28/2018
    Series:
    National Notifiable Diseases: Infectious Weekly Tables 2018 week 51
    Description:
    2018-51-table2C-H.pdf
    File Type:
    Filetype[PDF - 121.65 KB]